HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CIR Expert Panel Questions Skin Whitener Kojic Acid

This article was originally published in The Rose Sheet

Executive Summary

The Cosmetic Ingredient Review Expert Panel is seeking safety data for antioxidant ingredient kojic acid, a substance increasingly used as an alternative to controversial skin-whitener hydroquinone

You may also be interested in...



In Light Of European Ban, CIR Experts Will Revisit Disperse Blue 1

The Cosmetic Ingredient Review's Expert Panel plans to re-open a review of disperse blue 1 based largely on the European Union's decision to ban the hair-dye ingredient (see chart: "1Cosmetic Ingredient Review Report Status")

In Light Of European Ban, CIR Experts Will Revisit Disperse Blue 1

The Cosmetic Ingredient Review's Expert Panel plans to re-open a review of disperse blue 1 based largely on the European Union's decision to ban the hair-dye ingredient (see chart: "1Cosmetic Ingredient Review Report Status")

CIR Panel's Priorities For 2010 Include Triclosan, Amino Acids, Talc

The Cosmetic Ingredient Review's Expert Panel plans to evaluate 300 ingredients in 2010 - including triclosan, one of 17 priorities for the year (see chart: "1Cosmetic Ingredient Review 2010 Priority List")

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS016448

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel